Tenex Greenhouse Ventures
3
11M
2
1
0.33
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Burlingame. The company was established in North America in United States.
The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2006. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
Among the most popular fund investment industries, there are Health Care, Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Trinity Biosystems.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Tenex Greenhouse Ventures, startups are often financed by Sanderling Ventures. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Pelion Venture Partners, Northwest Technology Ventures. In the next rounds fund is usually obtained by Sanderling Ventures, Amgen Ventures, SR One.
The current fund was established by Alfred Mandel.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Follow on index
- 0.33
- Investments by industry
- Therapeutics (3)
- Biotechnology (3)
- Health Care (2)
- Biopharma (1)
- Drug Discovery (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Trinity Biosystems | 18 Jul 2006 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 21M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.